Bridelia atroviridis (Phyllanthaceae) Aqueous Extract Attenuates Scopolamine-induced Amnesia and Depression in Rat: Role of Cholinergic, Monoaminergic, and Antioxidant Mechanisms

References (57)

1. 1 Tissue sulfhydryl groups [DOI]
2. 2 Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids [DOI]
3. 3 Developments of a water-maze procedure for studying spatial learning in the rat [DOI]
4. 4 A simple practice guide for dose conversion between animals and human [DOI]
5. 5 Morris water maze: procedures for assessing spatial and related forms of learning and memory [DOI]
6. 6 A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data [DOI]
7. 7 Comprehensive Review on Alzheimer’s Disease: Causes and Treatment [DOI]
8. 8 THE REACTION OF ACETYLCHOLINE AND OTHER CARBOXYLIC ACID DERIVATIVES WITH HYDROXYLAMINE, AND ITS ANALYTICAL APPLICATION [DOI]
9. 9 Current and Future Treatments in Alzheimer Disease: An Update [DOI]
10. 10 Calcium and oxidative stress: from cell signaling to cell death [DOI]
11. 11 Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021 [DOI]
12. 12 Oxidative Stress and Psychological Disorders [DOI]
13. 13 The thiobarbituric acid reagent as a test for the oxidation of unsaturated fatty acids by various agents.
14. 14 Cholinergic modulation of the hippocampal region and memory function [DOI]
15. 15 Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease [DOI]
16. 16 Serotonin receptors involved in antidepressant effects [DOI]
17. 17 Activation of the genetically defined m1 muscarinic receptor potentiates N -methyl- d -aspartate (NMDA) receptor currents in hippocampal pyramidal cells [DOI]
18. 18 Antidepressant-Like Effect of Different Estrogenic Compounds in the Forced Swimming Test [DOI]
19. 19 Acetylcholine and memory: A long, complex and chaotic but still living relationship [DOI]
20. 20 Depression as a Risk Factor for Alzheimer’s Disease: A Systematic Review of Longitudinal Meta-Analyses [DOI]
21. 21 Curcumin in Health and Diseases: Alzheimer’s Disease and Curcumin Analogues, Derivatives, and Hybrids [DOI]
22. 22 Inhibition of flavonoids on acetylcholine esterase: binding and structure–activity relationship [DOI]
23. 23 Anxiety and Depression in Caregivers are Associated with Patient and Caregiver Characteristics in Alzheimer's Disease [DOI]
24. 24 Scopolamine-Induced Memory Impairment in Mice: Neuroprotective Effects of Carissa edulis (Forssk.) Valh (Apocynaceae) Aqueous Extract [DOI]
25. 25 Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders [DOI]
26. 26 Depression in Alzheimer's Disease: A Delphi Consensus on Etiology, Risk Factors, and Clinical Management [DOI]
27. 27 Measuring Anxiety-Like Behaviors in Rodent Models of Traumatic Brain Injury [DOI]
28. 28 Antiamnesic and Neuroprotective Effects of an Aqueous Extract of Ziziphus jujuba Mill. (Rhamnaceae) on Scopolamine-Induced Cognitive Impairments in Rats [DOI]
29. 29 Direct microdetermination of serum calcium [DOI]
30. 30 Thrombin-Induced Oxidative Stress Contributes to the Death of Hippocampal NeuronsIn Vivo: Role of Microglial NADPH Oxidase [DOI]
31. 31 Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamine [DOI]
32. 32 Molecular phylogenetics of Phyllanthaceae inferred from five genes (plastid atpB, matK, 3′ndhF, rbcL, and nuclear PHYC) [DOI]
33. 33 Scopolamine Administration Modulates Muscarinic, Nicotinic and NMDA Receptor Systems [DOI]
34. 34 The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT 3 receptors [DOI]
35. 35 Emilia coccinae (SIMS) G Extract improves memory impairment, cholinergic dysfunction, and oxidative stress damage in scopolamine-treated rats [DOI]
36. 36 Quercetin and its metabolites inhibit the membrane NADPH oxidase activity in vascular smooth muscle cells from normotensive and spontaneously hypertensive rats [DOI]
37. 37 Pyrrolidine dithiocarbamate protects against scopolamine-induced cognitive impairment in rats [DOI]
38. 38 LLDT-8 protects against cerebral ischemia/reperfusion injury by suppressing post-stroke inflammation [DOI]
39. 39 Enteromorpha prolifera Extract Improves Memory in Scopolamine-Treated Mice via Downregulating Amyloid-β Expression and Upregulating BDNF/TrkB Pathway [DOI]
40. 40 Bergapten Improves Scopolamine-Induced Memory Impairment in Mice via Cholinergic and Antioxidative Mechanisms [DOI]
41. 41 Soursop fruit extract mitigates scopolamine-induced amnesia and oxidative stress via activating cholinergic and Nrf2/HO-1 pathways [DOI]
42. 42 2-Phenylethynyl-butyltellurium enhances learning and memory impaired by scopolamine in mice [DOI]
43. 43 Amelioration of Scopolamine-Induced Amnesic, Anxiolytic and Antidepressant Effects of Ficus benghalensis in Behavioral Experimental Models [DOI]
44. 44 A COMPARATIVE ETHNOBOTANY OF THE MBUTI AND EFE HUNTER-GATHERERS IN THE ITURI FOREST, DEMOCRATIC REPUBLIC OF CONGO [DOI]
45. 45 Z-ligustilide isolated from Radix Angelicae sinensis ameliorates the memory impairment induced by scopolamine in mice [DOI]
46. 46 In Search of Memory Tests Equivalent for Experiments on Animals and Humans [DOI]
47. 47 Effects ofFicus umbellata(Moraceae) Aqueous Extract and 7-Methoxycoumarin on Scopolamine-Induced Spatial Memory Impairment in Ovariectomized Wistar Rats [DOI]
48. 48 Hydroethanolic Extract from Bridelia atroviridis Müll. Arg. Bark Improves Haematological and Biochemical Parameters in Nicotinamide‐/Streptozotocin‐Induced Diabetic Rats [DOI]
49. 49 [Effects of scopolamine on serotonin in the spinal cord and atria of morphine-dependent rats].
50. 50 In vitro Antioxidant and Antibacterial activity of Bridelia atroviridis (Arasado) [DOI]
51. 51 Pathophysiology of depression and mechanisms of treatment [DOI]
52. 52 Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation [DOI]
53. 53 Identifying health conditions associated with Alzheimer's disease up to 15 years before diagnosis: an agnostic study of French and British health records [DOI]
54. 54 Pharmacotherapy Evolution in Alzheimer’s Disease: Current Framework and Relevant Directions [DOI]
55. 55 Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma [DOI]
56. 56 Aducanumab: A new hope in Alzheimer's disease [DOI]
57. 57 Epileptic seizures and link to memory processes [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• In vitro Antioxidant and Antibacterial activity of Bridelia atroviridis (Arasado) — shares topic coverage
• Effect of Non-lesion Electrostimulation on Sensorimotor and Cognimotor Activities in Wister Rats — shares topic coverage
• Neuroprotective Effect of Butanol Fraction of Zapoteca portoricensis (Jacq.) H. M. Hern Root on Scopolamine Induced Memory Impairment in Rats — shares topic coverage
• Evaluation of the Nootropic Activity of the Ethanolic Leaf Extract of Couroupita guianensis in Scopolamine Induced Amnesia Models — shares topic coverage
• Neurobehavioral and Hematological Effects of Zapoteca portoricensis (Jacq.) H.M.Hern Root Ethylacetate Fraction against Scopolamine Induced Cognitive Impairment in Rats — shares topic coverage